Cryoablation plus chemotherapy regimen enhance anti-tumor immune response in a mouse model of Lewis lung cancer
Cryo + chemo can effectively inhibit the growth of lung cancer, prolong the survival period and activate the immune response, providing a theoretical basis for the combined treatment. How to maintain the immune response for a long time is the next problem to be solved.
Authors
- Shaohua Yan (ORCID: https://orcid.org/0000-0002-3339-3184)
- Hua Duan (ORCID: https://orcid.org/0000-0002-9768-2428)
- Bingli Qiao
- Xueni Fang
- Li Yang (ORCID: https://orcid.org/0000-0002-7880-2113)
- Tian Zhou (ORCID: https://orcid.org/0000-0002-3428-6778)
- Yang Cao (ORCID: https://orcid.org/0000-0001-7052-9346)
- Kaiwen Hu (ORCID: https://orcid.org/0000-0002-1258-9647)
Institutions
- Zhejiang Chinese Medical University (CN)
- Beijing University of Chinese Medicine (CN)
- Zhengzhou People's Hospital (CN)
Publication Details
- Journal
- International Journal of Hyperthermia
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1080/02656736.2024.2415365
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28